Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410001 · ClinicalTrials.gov registry record · Phase 1
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
A Phase 1 study of Spinal Cord Injury, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06410001: Recruiting Phase 1 study of Spinal Cord Injury, sponsored by University of Minnesota.
NCT06410001 is a Phase 1 study of Spinal Cord Injury that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 36 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06410001, a Phase 1 study of Spinal Cord Injury, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.
Primary Outcome
Incidence of adverse events (AEs) and serious adverse events (SAEs) including hypotension, other hemodynamic instability, infection, bleeding, significant pain, spasticity, or cerebrospinal fluid leak.
Conditions Studied
Interventions
- DEVICE Epidural Spinal Cord Stimulation System
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2030-07-30 |
| Phase | Phase 1 |
What NCT06410001 shows while recruiting
NCT06410001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Epidural Spinal Cord Stimulation System is the first listed.
NCT06410001 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06410001 about?
NCT06410001 is a clinical study titled "CE-STAND: Cervical Epidural STimulation After Neurologic Damage". CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.
What is the current status of trial NCT06410001?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2026-03-01. Estimated completion is 2030-07-30.
What conditions does trial NCT06410001 study?
This clinical trial studies the following conditions: Spinal Cord Injury.
What interventions are being tested in trial NCT06410001?
The interventions under investigation include: Epidural Spinal Cord Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT06410001?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06410001 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06410001's enrollment target sits among peer trials
36 41st of 99 higher than 59 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury
RECRUITING · Phase 1
-
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
RECRUITING · Phase 1
-
Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury
COMPLETED · Phase 1
-
A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries
COMPLETED · Phase 1
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI